Evolus Ownership | Who Owns Evolus?

Overview Forecast RevenueFinancials Chart Transcripts

Evolus Ownership Summary

Evolus is owned by 70.49% institutional investors, 14.68% insiders, and 14.82% retail investors. Nantahala capital management is the largest institutional shareholder, holding 9.89% of EOLS shares. BioPharma Credit Ord is the top mutual fund, with 8.78% of its assets in Evolus shares.

EOLS Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Evolus	70.49%	14.68%	14.82%
Sector	Healthcare Stocks	35.58%	11.87%	52.55%
Industry	Specialty & Generic Drug Manufacturers Stocks	20.67%	13.90%	65.43%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Nantahala capital management	6.38M	9.89%	$26.21M
Blackrock	4.01M	6.82%	$43.49M
Blackrock funding, inc. /de	4.29M	6.66%	$17.63M
Caligan partners lp	4.14M	6.41%	$25.41M
Vanguard group	3.34M	5.16%	$22.22M
Braidwell lp	3.11M	4.82%	$12.76M
Frazier life sciences management	2.63M	4.08%	$10.81M
Soleus capital management	2.25M	3.48%	$9.23M
Stonepine capital management	1.76M	2.73%	$7.23M
Millennium management	1.46M	2.27%	$6.01M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Allostery investments lp	60.00K	7.04%	$552.60K
Caligan partners lp	4.14M	3.33%	$25.41M
Stonepine capital management	1.76M	2.90%	$7.23M
Awh capital	625.00K	2.33%	$2.57M
Altium capital management lp	685.00K	2.15%	$7.56M
Soviero asset management, lp	680.37K	1.40%	$2.80M
Cm management	400.00K	1.37%	$1.64M
Nantahala capital management	6.38M	0.96%	$26.21M
Prospect capital advisors	208.10K	0.66%	$1.28M
Potomac capital management	141.50K	0.51%	$581.57K

Top Buyers

Holder	Shares	% Assets	Change
Perceptive advisors	1.29M	0.10%	1.29M
Soleus capital management	2.25M	0.37%	1.18M
Caligan partners lp	4.14M	3.33%	796.97K
Blackrock	4.01M	0.00%	747.40K
Goldman sachs group	1.09M	0.00%	735.66K

Top Sellers

Holder	Shares	% Assets	Change
Frontier capital management	270.51K	0.01%	-1.39M
Tri locum partners lp	-	-	-1.24M
Soros fund management	-	-	-995.49K
Schroder investment management group	-	-	-986.47K
D. e. shaw	559.05K	0.00%	-982.05K

New Positions

Holder	Shares	% Assets	Change	Value
Perceptive advisors	1.29M	0.10%	1.29M	$5.29M
Vanguard fiduciary trust	424.66K	0.00%	424.66K	$1.75M
Prospect capital advisors	208.10K	0.66%	208.10K	$1.28M
Ci private wealth	79.94K	0.00%	79.94K	$328.55K
Fuller & thaler asset management	55.51K	0.00%	55.51K	$228.16K

Sold Out

Holder	Change
National bank of canada /fi/	-2.00
True wealth design	-4.00
Coldstream capital management	-12.00
Lindbrook capital	-21.00
Jpl wealth management	-23.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	150	-13.29%	45,445,549	-7.67%	70	1.22%	82	-11.83%	41	-16.33%
Dec 31, 2025	94	-43.37%	19,539,863	-64.07%	30	0.42%	54	-32.50%	21	-61.11%
Sep 30, 2025	71	-60.77%	16,258,044	-72.12%	25	0.31%	35	-61.96%	19	-62.75%
Jun 30, 2025	180	-1.64%	58,292,237	8.05%	90	1.26%	91	5.81%	51	-15.00%
Mar 31, 2025	183	9.58%	54,281,287	4.55%	85	1.26%	86	4.88%	61	29.79%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
BioPharma Credit Ord	5.66M	8.78%	-99.14K
Vanguard US Total Market Shares ETF	1.68M	2.65%	-
Vanguard Total Stock Mkt Idx Inv	1.67M	2.53%	-
iShares Russell 2000 ETF	1.32M	2.01%	11.14K
Vanguard Institutional Extnd Mkt Idx Tr	748.07K	1.14%	5.06K
Schroder US Smaller Companies Acc	718.22K	1.11%	-15.14K
Oberweis Micro-Cap Growth	677.60K	1.05%	-
Oberweis Micro-Cap	677.60K	1.05%	-
Xtrackers S&P 500 Swap ETF 1C	578.12K	0.92%	-153.31K
CREF Stock R1	572.75K	0.90%	245.42K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 20, 2026	Avelar Rui	See Remarks	Sell	$14.82K
Mar 20, 2026	MOATAZEDI DAVID	See Remarks	Sell	$64.93K
Mar 17, 2026	MOATAZEDI DAVID	See Remarks	Sell	$570.56K
Mar 17, 2026	Avelar Rui	See Remarks	Sell	$146.63K
Dec 22, 2025	MOATAZEDI DAVID	See Remarks	Sell	$75.36K

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	-	4
2025 Q4	-	2
2025 Q3	1	1
2025 Q2	1	5
2025 Q1	-	6

EOLS Ownership FAQ

Who Owns Evolus?

Evolus shareholders are primarily institutional investors at 70.49%, followed by 14.68% insiders and 14.83% retail investors. The average institutional ownership in Evolus's industry, Specialty & Generic Drug Manufacturers Stocks, is 20.67%, which Evolus exceeds.

Who owns the most shares of Evolus?

Evolus’s largest shareholders are Nantahala capital management (6.38M shares, 9.89%), Blackrock (4.01M shares, 6.82%), and Blackrock funding, inc. /de (4.29M shares, 6.66%). Together, they hold 23.36% of Evolus’s total shares outstanding.

Does Blackrock own Evolus?

Yes, BlackRock owns 6.82% of Evolus, totaling 4.01M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 43.49M$. In the last quarter, BlackRock increased its holdings by 747.4K shares, a 22.92% change.

Who is Evolus’s biggest shareholder by percentage of total assets invested?

Allostery investments lp is Evolus’s biggest shareholder by percentage of total assets invested, with 7.04% of its assets in 60K Evolus shares, valued at 552.6K$.

Who is the top mutual fund holder of Evolus shares?

BioPharma Credit Ord is the top mutual fund holder of Evolus shares, with 8.78% of its total shares outstanding invested in 5.66M Evolus shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools